CIT can broadcast your seminar, conference or meeting live to a world-wide audience over the Internet as a real-time streaming video. The event can be recorded and made available for viewers to watch at their convenience as an on-demand video or a downloadable file. CIT can also broadcast NIH-only or HHS-only content.
Marijuana and Cannabinoids: A Neuroscience Research Summit (Day 2)
To ask QUESTIONS during the Summit Q&A sessions: Tweet your questions using the hashtag #MJNeuroSummit
Marijuana and Cannabinoids: A Neuroscience Research Summit is being convened by the National Institutes of Health (NIH), which will focus on the neurological and psychiatric effects of marijuana, other cannabinoids, and the endocannabinoid system. Both the adverse and the potential therapeutic effects of the cannabinoid system will be discussed. The goal of this summit is to ensure evidence-based information is available to inform practice and policy, particularly important at this time given the rapidly shifting landscape regarding the recreational and medicinal use of marijuana.
This two day summit is being sponsored by several NIH Institutes and Centers: the National Institute on Drug Abuse (NIDA); the National Institute on Alcohol Abuse and Alcoholism (NIAAA); the National Center for Complementary and Integrative Health (NCCIH); the National Institute of Mental Health (NIMH); and the National Institute of Neurological Disorders and Stroke (NINDS).
Marijuana and cannabinoids : a neuroscience research summit / NIDA, NIAAA, NCCIH, NIMH and NINDS.
Author:
Marijuana and Cannabinoids: A Neuroscience Research Summit National Institute on Drug Abuse, National Institute on Alcohol Abuse and Alcoholism (U.S.), National Center for Complementary and Integrative Health (U.S.), National Institute of Mental Health (U.S.), National Institute of Neurological Disorders and Stroke (U.S.),
Publisher:
Abstract:
(CIT): Marijuana and Cannabinoids: A Neuroscience Research Summit is being convened by the National Institutes of Health (NIH), which will focus on the neurological and psychiatric effects of marijuana, other cannabinoids, and the endocannabinoid system. Both the adverse and the potential therapeutic effects of the cannabinoid system will be discussed. The goal of this summit is to ensure evidence-based information is available to inform practice and policy, particularly important at this time given the rapidly shifting landscape regarding the recreational and medicinal use of marijuana. This two day summit is being sponsored by several NIH Institutes and Centers: the National Institute on Drug Abuse (NIDA); the National Institute on Alcohol Abuse and Alcoholism (NIAAA); the National Center for Complementary and Integrative Health (NCCIH); the National Institute of Mental Health (NIMH); and the National Institute of Neurological Disorders and Stroke (NINDS).
Subjects:
Cannabinoids--pharmacology Cannabinoids--therapeutic use Marijuana Abuse--complications Marijuana Smoking Medical Marijuana
